JY
BMGL

Jeff Yass’s Basel Medical BMGL Stock Holding History

Jeff Yass’s Portfolio BMGL Stock Details BMGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,274
Closed -$7.49K – 14438
2025
Q4 		$7.49K Buy
+1,274
New +$18.8K ﹤0.01% 12077

Other funds holding BMGL

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's BMGL Position: Q1 2026 in Review

Jeff Yass sold out of Basel Medical (BMGL) in Q1 2026, closing a stake of 1,274 shares — an estimated $7.49K sold.

Jeff Yass first reported a position in BMGL in Q4 2025 and held it in 1 quarter. The position peaked at $7.49K in Q4 2025. 4 funds tracked by Wall St. Rank hold BMGL as of Q1 2026.

  • Jeff Yass reported no remaining Basel Medical position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 1,274 Basel Medical shares in Q1 2026, an estimated $7.49K.
  • Jeff Yass first reported a position in Basel Medical in Q4 2025 and held it in 1 quarter.
  • Jeff Yass's Basel Medical position peaked at $7.49K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Basel Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.